These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29956803)
1. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway. Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803 [TBL] [Abstract][Full Text] [Related]
2. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways. Yuan F; Gao Q; Tang H; Shi J; Zhou Y Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169857 [TBL] [Abstract][Full Text] [Related]
3. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
5. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247 [TBL] [Abstract][Full Text] [Related]
6. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
7. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway. Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793 [TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M; Zhou LY; Xu N; An Q Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p. Yu L; Chen D; Song J Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899 [TBL] [Abstract][Full Text] [Related]
10. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties. Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071 [TBL] [Abstract][Full Text] [Related]
11. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling. Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603 [TBL] [Abstract][Full Text] [Related]
12. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway. Gu F; Zhou Y; Tian L; Chen J; Zhang C; Huang Z; Yu W; Xie K Sci Rep; 2024 Sep; 14(1):21130. PubMed ID: 39256509 [TBL] [Abstract][Full Text] [Related]
13. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway. Chen M; Du Y; Qui M; Wang M; Chen K; Huang Z; Jiang M; Xiong F; Chen J; Zhou J; Jiang F; Yin L; Tang Y; Ye L; Zhan Z; Duan JΑ; Fu HΑ; Zhang X Oncol Rep; 2013 Feb; 29(2):430-6. PubMed ID: 23151908 [TBL] [Abstract][Full Text] [Related]
14. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer. Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892 [TBL] [Abstract][Full Text] [Related]
15. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma. Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409 [TBL] [Abstract][Full Text] [Related]
16. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway. Zhang Z; Rui W; Wang ZC; Liu DX; Du L Oncol Rep; 2017 Aug; 38(2):1172-1180. PubMed ID: 28656293 [TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
18. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
19. Ophiopogonin B induces reactive oxygen species‑dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma. Dong W; Dong Q; Ding H Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080657 [TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer. Luo F; Zhao Y; Liu J Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]